Today: 7 February 2026
Subscribe
Browse Category

NYSE:MCK News 4 December 2025 - 6 February 2026

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson shares fell 2.1% to $937.31 Friday, retreating after a 16.5% surge on an upgraded 2026 profit forecast and plans to spin off its medical-surgical division. Quarterly revenue rose 11% to $106.2 billion, with adjusted EPS up 16% to $9.34. The company filed an automatic shelf registration for future securities sales. TD Cowen raised its price target to $1,012, citing strong oncology and prescription-tech results.
6 February 2026
···
McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook

McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook

McKesson shares slipped 0.1% to $956.71 in early New York trading Friday after a 16.5% surge the previous session. The company raised its fiscal 2026 adjusted earnings guidance to $38.80-$39.20 per share and confirmed plans to spin off its medical-surgical unit with an IPO targeted for late 2027. Fiscal Q3 revenue rose 11% to $106.2 billion.
6 February 2026
·····
McKesson stock jumps 16% after forecast lift — traders eye the next catalyst for MCK

McKesson stock jumps 16% after forecast lift — traders eye the next catalyst for MCK

McKesson shares surged 16.5% to $957.80 after hours Thursday as the company raised its full-year adjusted earnings forecast and reported quarterly profit and revenue above Wall Street estimates. Q3 revenue reached $106.16 billion with adjusted EPS at $9.34. McKesson confirmed its planned medical-surgical unit spin-off remains on track for a 2027 IPO.
6 February 2026
·····
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
·······
McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson Corporation (NYSE: MCK) ended the Christmas Eve session essentially flat, then edged slightly lower in thin after-hours trading—an unsurprising setup for a holiday-shortened day when liquidity typically dries up and price moves can be noisy. Here’s what happened after the bell on Wednesday, December 24, 2025, what the latest forecasts and analyst takes are saying today, and what investors may want on their radar before the U.S. stock market’s next regular session on Friday, December 26, 2025. Nasdaq McKesson stock after the bell: the key numbers (Dec. 24, 2025) McKesson shares closed at $826.43, up $0.71 (+0.09%) in the
25 December 2025
·····
Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Updated: Wednesday, December 24, 2025 (Christmas Day is Thursday, Dec. 25) Christmas Day in Canada is a statutory holiday, which means most retailers go dark—malls lock up, big-box stores turn off the lights, and even many grocery aisles are quiet. Time and Date But last-minute needs don’t take the day off. Whether it’s cold medicine, diapers, a phone charger, or a missing ingredient for dinner, Canadians still look for a handful of reliable places that tend to stay open on December 25. Based on current local holiday-hours coverage published during the Dec. 24–25 news cycle—plus official retailer schedules—here’s where you can still
25 December 2025
······
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
·····
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (NYSE: MCK) is ending 2025 as one of the standout performers in U.S. healthcare — but as of Wednesday, December 3, its stock is taking a breather. At the close, McKesson shares finished at $805.37, down 2.93% on the day and roughly 10% below their recent 52‑week high near $895, even after a powerful rally through most of the year.Wallstrank+2MarketWatch+2 Behind that pullback is a mix of profit‑taking after record highs, institutional portfolio shuffling, and investors digesting a wave of new guidance, long‑term targets, oncology initiatives and valuation debates. This article walks through: Key Takeaways on McKesson Stock
4 December 2025
····

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop